Global Cord Blood (NYSE:CO) Shares Pass Above 200-Day Moving Average - Should You Sell?

Key Points

• Global Cord Blood Co. shares have surpassed their 200-day moving average, trading at $1.45 after reaching a high of $1.45 during the session.
• The company's market capitalization is approximately $176.25 million, with a low PE ratio of 2.27, suggesting potential undervaluation in the stock market.
• Global Cord Blood offers a range of cord blood banking services, including processing, storage, and matching services for stem cell transplants.

Global Cord Blood Co. (NYSE:CO - ) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.00 and traded as high as $1.45. Global Cord Blood shares last traded at $1.45, with a volume of 950 shares trading hands.

Global Cord Blood Trading Up 163.6%

The company has a market cap of $176.25 million, a PE ratio of 2.27 and a beta of 0.16. The stock has a 50 day moving average price of $0.97 and a 200 day moving average price of $1.00.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.